ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 130 filers reported holding ASCENDIS PHARMA A/S in Q3 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,113,000 | -20.9% | 26,529 | +12.4% | 0.44% | +26.1% |
| Q4 2020 | $3,936,000 | -21.8% | 23,599 | -27.6% | 0.35% | -29.4% |
| Q3 2020 | $5,031,000 | -1.0% | 32,599 | -5.2% | 0.49% | +3.3% |
| Q2 2020 | $5,084,000 | +38.6% | 34,373 | +5.5% | 0.48% | +4.1% |
| Q1 2020 | $3,668,000 | -64.3% | 32,573 | -55.8% | 0.46% | -45.7% |
| Q4 2019 | $10,263,000 | +44.4% | 73,773 | 0.0% | 0.85% | -23.0% |
| Q3 2019 | $7,106,000 | -16.4% | 73,773 | 0.0% | 1.10% | -5.5% |
| Q2 2019 | $8,495,000 | +5.7% | 73,773 | +8.1% | 1.16% | +58.5% |
| Q1 2019 | $8,036,000 | +120.1% | 68,273 | +17.2% | 0.73% | +77.9% |
| Q4 2018 | $3,651,000 | -44.4% | 58,273 | -37.1% | 0.41% | -45.4% |
| Q3 2018 | $6,567,000 | +26.5% | 92,673 | +18.7% | 0.75% | +5.3% |
| Q2 2018 | $5,192,000 | -16.8% | 78,048 | -18.3% | 0.72% | -24.5% |
| Q1 2018 | $6,244,000 | +20.4% | 95,474 | -26.3% | 0.95% | +55.7% |
| Q4 2017 | $5,187,000 | +10.5% | 129,474 | 0.0% | 0.61% | -9.1% |
| Q3 2017 | $4,693,000 | +4.6% | 129,474 | -19.9% | 0.67% | -12.1% |
| Q2 2017 | $4,486,000 | -37.3% | 161,617 | -36.7% | 0.76% | -45.5% |
| Q1 2017 | $7,153,000 | +8.2% | 255,455 | -21.8% | 1.40% | -16.4% |
| Q4 2016 | $6,611,000 | +24.8% | 326,622 | +24.0% | 1.67% | +94.1% |
| Q3 2016 | $5,296,000 | +52.4% | 263,500 | +0.6% | 0.86% | -4.4% |
| Q2 2016 | $3,474,000 | +185.9% | 261,800 | +274.0% | 0.90% | +615.9% |
| Q1 2015 | $1,215,000 | – | 70,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |